These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16280216)

  • 1. Distribution of liposomal breviscapine in brain following intravenous injection in rats.
    Lv W; Guo J; Li J; Huang L; Ping Q
    Int J Pharm; 2005 Dec; 306(1-2):99-106. PubMed ID: 16280216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of liposomal bifendate in liver following intravenous injection in mice.
    Zhipeng C; Jiabi Z; Hongxuan C; Yan-yu X; Jun C; Bao-chang C
    J Drug Target; 2010 Sep; 18(8):627-36. PubMed ID: 20166805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of breviscapine liposomes following intravenous injection in Beagle dogs].
    Lo WL; Guo JX; Ping QN; Li J; Zhao CW; Zhang L
    Yao Xue Xue Bao; 2006 Jan; 41(1):24-9. PubMed ID: 16683523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats.
    Lv W; Guo J; Ping Q; Song Y; Li J
    Int J Pharm; 2008 Jul; 359(1-2):118-22. PubMed ID: 18502062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of breviscapine and its beta-cyclodextrin complex in rats].
    Zhang HY; Ping QN; Guo JX; Cao F
    Yao Xue Xue Bao; 2005 Jun; 40(6):563-7. PubMed ID: 16144326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization, and biodistribution of breviscapine proliposomes in heart.
    Fei X; Chen X; Liang G; Yue-Jian C; Hao W; Ning G; Jia-Bi Z
    J Drug Target; 2009 Jun; 17(5):408-14. PubMed ID: 19555267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oral bioavailability of breviscapine after encapsulation in a liposomal formulation.
    Zhong HJ; Deng YJ; Yang BH; Li CL; Du S
    Pharmazie; 2005 Jun; 60(6):475-6. PubMed ID: 15997842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization, biodistribution and targeting evaluation of breviscapine lipid emulsions following intravenous injection in mice.
    Xiong F; Wang H; Chen YJ; Geng KK; Gu N; Zhu JB
    Drug Deliv; 2011 Feb; 18(2):159-65. PubMed ID: 21028951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on pharmacokinetics of scutellarin in rabbits.
    Liu YM; Lin AH; Chen H; Zeng FD
    Yao Xue Xue Bao; 2003 Oct; 38(10):775-8. PubMed ID: 14730903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and pharmacokinetics in rabbits of breviscapine unilamellar vesicles.
    Lv W; Guo J; Li J; Wang X; Li J; Ping Q
    Drug Dev Ind Pharm; 2006 Mar; 32(3):309-14. PubMed ID: 16556535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and pharmacokinetics of nimodipine-loaded liposomes.
    Wang Z; Deng Y; Zhang X; Wang T; Wu F
    J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of breviscapine in dogs and rabbits following single intravenous administration].
    Liu Q; Luo G; Wang Y; Ma Y; Zhang R
    Zhong Yao Cai; 2005 Oct; 28(10):913-6. PubMed ID: 16479930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivesicular liposome formulation for the sustained delivery of breviscapine.
    Zhong H; Deng Y; Wang X; Yang B
    Int J Pharm; 2005 Sep; 301(1-2):15-24. PubMed ID: 16023316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
    Zhou Y; Ning Q; Yu DN; Li WG; Deng J
    J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the distribution of breviscapine in the brain by different administration routes].
    Shi SL; Xu LY; Wu JJ; Li CY; Ge WH; Dai WY
    Yao Xue Xue Bao; 2009 May; 44(5):515-8. PubMed ID: 19618729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.
    Yachi K; Harashima H; Kikuchi H; Sudo R; Yamauchi H; Ebihara K; Matsuo H; Funato K; Kiwada H
    Biopharm Drug Dispos; 1996 Oct; 17(7):589-605. PubMed ID: 8894117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization.
    Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q
    Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of polyamidoamine (PAMAM) dendrimers on the solubility and pharmacokinetics of breviscapine].
    Lu JJ; Wu ZH; Ping QN
    Yao Xue Xue Bao; 2009 Feb; 44(2):197-202. PubMed ID: 19408693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of different doxorubicin-salt aggregates on the leakage of liposomal doxorubicin in vitro and long circulation in vivo].
    Zhang L; Pan H; Liu M; Lu WY
    Yao Xue Xue Bao; 2004 Dec; 39(12):1018-22. PubMed ID: 15813033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.